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There are few encounters with massive thyromegaly and intrathoracic extension as a result of the general
usage of iodized salt and bread, which was an early therapeutic intervention for thyroid disorders.
However, cervical goiter enlargement over time may extend into the thoracic space, causing respiratory
distress, dysphagia, and vascular compression. Hence, even though it may be asymptomatic, there is
potential for sudden enlargement (secondary to hemorrhage), cystic degeneration, or malignant change
that can be life threatening and may require surgery. Patients who underwent surgery with curative
intent for intrathoracic goiter from January 1970 to July 2002 were included in this retrospective study at
the thoracic surgical division of Taipei Veteran General Hospital in Taipei, Taiwan. Data were compared
between patients 65 years of age (elderly group) and patients <65 years of age (younger group). Patient
characteristics, hospital course, surgical mortality, morbidity, and survival were compared between
patients in these two age groups. Total surgical treatment was given in 153 patients (men, 85; women,
68) with a mean age of 66.9 years (range, 41e86 years) who were enrolled in our study. A total of 95
(62.1%) patients were at least 65 years of age (mean age, 74.2 years) and 58 (37.9%) patients were younger
than 65 years of age (mean age, 55 years; p < 0.001). Mean hospitalization was 9.5 days (range, 4e115
days), and the mean follow-up period was 4.5 years (range, 4 monthse14 years). The elderly group had
a signiﬁcantly higher risk of respiratory syndromes (63.2% versus 34.5%, p < 0.001) and were predom-
inantly men (63.2% versus 43.1%, p < 0.001). However, the elderly group had a signiﬁcantly lower
incidence of malignancy (0% versus 12.1%, p < 0.001). The pathology was generally found to be benign in
elderly patients, but seven (12.1%) patients presented with carcinoma in the younger group. The
mortality and complications were observed in 1.3% and 10.5% of the all patients. The results of this study
suggest that curative surgery for intrathoracic goiter in elderly patients may result in high risks of acute
airway compression compared with younger patients. Our data suggest that an age of 65 years or older
should not be contraindicated for curative surgery in intrathoracic goiter patients. Surgical resection is
recommended for all intrathoracic goiters due to high risks of acute airway compression and occult
malignancy.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Globally, there are more than 80,000 patients who received
surgical procedures because of neoplastic, inﬂammatory and
endocrine abnormalities of the thyroid gland in the globally1.
The natural development of thyroid goiter is characterized byterest.
f Radiation Oncology, Mackay
Taipei City 10449, Taiwan.
n).
iwan Society of Geriatric Emergenprogressive growth2 and may occasionally extend into the thoracic
cavity, presenting itself as an intrathoracic tumor, which poses
a diagnostic dilemma3,4. Intrathoracic goiter constitutes almost 5%
of all resected mediastinal tumors and is commonly found in the
pretracheal space as an intrathoracic extension of the thyroid goiter
in the neck5. With the aging of the population and longer life
expectancy, diagnosis of intrathoracic goiter and surgical treatment
in the elderly patients has become more frequent. For the treat-
ment of intrathoracic goiter, partial or total thyroidectomy, if
applicable, offers the best palliation of airway compression and
chance for cure. However, surgical treatment for intrathoraciccy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Age and sex distribution for intrathoracic goiter.
Intrathoracic Goiter in the Elderly 9goiter has been considered to be themost difﬁcult, not only because
of the biologic aggressiveness of the cancer but also its anatomic
characteristics. Although the numbers of elderly patients with
a diagnosis of potentially resectable intrathoracic goiter are
increasing and the treatment quality is reﬁned along with
improvement of perioperative care, there is still contradictory data
on the indication for surgery in such patients. Although there is no
well-established cutoff to deﬁne a patient as “elderly” for thoracic
surgery, 65 years has been used for assessing the treatment
outcome of intrathoracic goiter patients bymost studies. For elderly
patients, the ability to tolerate such extensive operation is usually
taken into account. However, little is known about surgical
outcome in this population. The objective of this retrospective
study is to evaluate the effect of age on the symptoms, morbidity,
mortality and outcome of surgery in intrathoracic goiter patients.
2. Materials and methods
We retrospectively reviewed the medical charts of patients with
intrathoracic goiter who underwent surgery with curative intent
from January 1970 to July 2002 in onemedical center. Patients were
investigated with a standard preoperative protocol that included
routine chest radiography, thyroid function tests, and computed
tomography (CT) scans of the neck and thorax. Thyrotoxic patients
were rendered euthyroid prior to surgery. The possibility of trans-
thoracic procedures was explained, and informed consent was
obtained. CT scan delineated the extent of the intrathoracic goiters.
The degree and level of critical organ compression or deviation
provided by CT scan is imperative to the selection of optimal
methods of surgical intervention and intubation by the physicians.
We deﬁned intrathoracic goiter as either the lower extent of the
goiter having transgressed the fourth thoracic vertebra6 or at least
50% of the goiter7 residing within the thorax. Large thyroid goiters
with inferior borders at the thoracic inlet were not included in our
study.
Patients were divided into elderly (65 years) and younger (<65
years) groups. The management of intrathoracic goiter was dis-
cussed by a multidisciplinary team at our institution. The trans-
cervical resection technique was used for most intrathoracic goiter
patients or combined with transthoracic thyroidectomy (thora-
cotomy or sternotomy) for some lower positions, huge tumors, or
primary intrathoracic goiters. Clinical data, including medical
history, tumor characteristics, postoperative course, and survival,
were collected from medical records. Postoperative follow-up was
conducted every 3 months for the ﬁrst 2 years and every 6 months
thereafter. The workup included chest roentgenography, neck and
chest CT scans, and serum levels to measure thyroid function.
Tumor progression or recurrence was diagnosed in the presence of
biopsy-proven malignancy or positive ﬁndings on at least two
different types of clinical examination as deﬁned above. The
primary endpoint of this study was the symptom, outcome of
surgery, including in-hospital morbidity and mortality. The
secondary endpoint was cancer survival. In patients with disease
recurrence, salvage therapy was provided at the discretion of the
treating physician.
Statistical analysis was performed using the independent t-test
and c2 test or Fisher exact test as appropriate. The SPSS/PCt
Advanced Statistics 12.0 software package (SPSS Inc., Chicago, IL,
USA) was used. A difference was considered signiﬁcant if the
p value was less than 0.05.
3. Results
During the study period, 153 patients with intrathoracic goiters
received thyroidectomy with curative intent, of whom 95 (62.1%)patients were in the elderly group and 58 (37.9%) patients were in
the younger group. The mean age of the entire patient group was
66.9 years (range, 41e86 years). The mean time duration of
hospitalization was 9.5 days (range, 4e115 days) and the mean
follow-up time was 4.5 years (range, 4 monthse14 years). The
elderly group had a signiﬁcantly higher age and were predomi-
nantly men (Fig. 1). In elderly patients, the mean tumor weight was
relatively increased compared with younger patients, but with no
signiﬁcant difference. However, the elderly group had a signiﬁ-
cantly lower incidence of malignancy (0% versus 12.1%; p < 0.001).
The frequency with which intrathoracic goiters are found on the
right side was signiﬁcant in our studies, but there was no difference
between either group. Progressive dyspnea was the most common
clinical symptom in both groups (Table 2) and airway compressive
syndrome was more signiﬁcant in elderly patients (63.2% versus
34.5%; p < 0.001). Other than age, sex, and histologic classiﬁcation,
there were no signiﬁcant differences between the two groups in
tumor weight, tumor location, and approach method (Table 1).
The postoperative complication (Table 4) rate was 12.7% in
elderly patients and 6.9% in younger patients with no signiﬁcant
difference in the two groups. Recurrent laryngeal nerve palsy was
the major complication in both groups (elderly versus younger:
6.4% versus 5.1%, respectively). Other complications included
postoperative bleeding and wound infection in both groups (2.1%
versus 1.7%). Two patients (2.1%) required intensive respiratory care
following the operation due to pneumonia (one patient) and pro-
longed mechanical ventilation because of respiratory failure (one
patient) in the elderly group. One patient with known ischemic
heart disease died a few days following the operation in the elderly
group and the other patient died due to postoperative hypovolemic
shock in younger group.
As a result of physician concerns about poor tolerance, elderly
patients received more intense therapy and had longer post-
operative hospital stays and greater morbidity. There was no
difference in morbidity and mortality rate between the two groups
(Table 3).
4. Discussion
Intrathoracic goiter was ﬁrst described by Haller8 in 1749. The
representation of intrathoracic goiter varies from less than 1%9 to
more than 20%10 among patients who underwent thyroidectomy.
Crile9 described the intrathoracic goiter as that which extends
down to the aortic arch. Hedayati and McHenry11 described every
thyroid that extends below the manubrium as an intrathoracic
goiter. Lindskog and Goldenberg6 considered intrathoracic goiter,
a lesion of the thyroid, extending to the fourth thoracic vertebra on
chest radiography. Katlic and colleagues7 proposed the most
representative deﬁnition from the clinical point of view; they
classiﬁed intrathoracic goiter withmore than 50% of the glandmass
inferior to the sternal notch. As a summary of these descriptions in
Table 3
Comparison of complications between elderly and younger patients.
No. of patients (%)
Patients 65 yr Patients <65 yr
(N ¼ 95) (N ¼ 58)
Hoarseness 5 (5.3%) 2 (3.4%)
Wound infection 2 (2.1%) 1 (1.7%)
Aspiration pneumonia 1 (1.1%)
Subcutaneous emphysema 1 (1.1%)
Respiratory failure (M.G.) 1 (1.1%)
Bilateral vocal cord paralysis 1 (1.1%) 1 (1.7%)
AMI* 1 (1.1%)
AMI ¼ acute myocardial ischemia; * Fisher’s exact test, p ¼ 0.07.
Table 1
Comparison of presenting symptoms of patients with intrathoracic goiter.
Presenting symptoms/groups Patients 65 yr Patients <65 yr
(N ¼ 95) (N ¼ 58)
Dyspnea * 42 (44.2%) 13 (22.4%)
Cough * 32 (33.7%) 11 (19.0%)
Neck mass 32 (33.7%) 12 (20.7%)
Asymptomatic 26 (27.4%) 11 (19.0%)
Chest tightness 24 (25.3%) 2 (3.5%)
Dysphagia 7 (7.4%) 1 (1.7%)
Thyroitoxic symptom 7 (7.4%) 0
Hoarseness * 7 (7.4%) 0
Hemoptysis * 5 (5.3%) 0
Body weight loss 3 (3.2%) 0
SVC syndrome 3 (3.2%) 1 (1.7%)
M.G. 2 (2.1%) 0
Sleep apnea * 0 1 (1.7%)
*Fisher’s exact test, p ¼ 0.01.
W.-C. Huang et al.10literature, we deﬁned the intrathoracic goiter as either the lower
extent of the goiter having at least 50% of the goiter residing within
the thorax or having transgressed the fourth thoracic vertebra if
there was no available neck or chest CT in our study. Large thyroid
goiters with inferior borders at the thoracic inlet were not included
in the study.
The origins of the intrathoracic goiters are classiﬁed into two
groups. One is the actual, primary intrathoracic or ectopic goiter. It
germinates in the mediastinum congenitally and the blood supply
has been found to come from the thyroid ima artery, the aorta, the
subclavian artery, or the internal mammary artery12,13, but it has no
direct connection with the cervical thyroid gland. This group
describes less than 1% of surgically removed goiters10,12. The other
most common group describes the acquired intrathoracic goiter
which initially arises from the cervical thyroid gland and then, as it
grows over time, descends along a fascia plane and through the
thoracic inlet into the mediastinum7. Lahey and Swinton14
described the anatomic factors responsible for that descent. In
our study, we had one patient with ectopic intrathoracic goiter in
elderly group (0.7%), while the others belonged to the acquired
intrathoracic goiters amongst our patients (Table 3). We separatedTable 2
Comparison of characteristics of patients undergoing surgery for intrathoracic
goiter.
Characteristics Patients 65 yr Patients <65 yr p
(N ¼ 95) (N ¼ 58)
Genderdno (%)
Male 60 (63.2%) 25 (43.1%)
Female 35 (36.8%) 33 (56.9%) <0.001*
Mean age  SDdyr 71.2 55 <0.001*
Mean tumor weight  SD
(range)dgm
220.343.7
(123-353)
176.555.7
(81-331)
0.37
Tumor location
Right side 62 (65.3%) 33 (56.9%)
Left side 22 (23.2%) 13 (22.4%)
Bilateral 11 (11.6%) 11 (19%) NS
Approach site
Collar 73 (76.8%) 46 (79.3%)
CollarþTransthoracic 22 (23.2%) 12 (20.7%) NS
Histological classiﬁcationdno. (%)
Multiple non-toxic goiter 88 (92.6%) 46 (79.3%)
Multiple toxic goiter 2 (2.1%) 1 (1.7%)
Adenoma 5 (5.3%) 4 (6.9%) NS
Goiter with carcinoma 7 (12.1%)
Papillary carcinoma 0 3 (5.2%)
Follicular carcinoma 0 2 (3.4%)
Hurthle cell carcinoma 0 2 (3.4%) <0.001*
Fisher’s exact test: NS ¼ no signiﬁcant difference; * ¼ signiﬁcant difference.the acquired intrathoracic goiters into three categories (Table 1):
One is growing from right thyroid gland (elderly versus younger:
65.3% and 56.9%), one is from left side gland (elderly versus
younger: 23.2% and 22.4%), and the other is from bilateral thyroid
glands (elderly versus younger: 11.6% and 19%). Most goiters were
from right thyroid gland and no difference was seen between the
elderly and younger groups.
According the intrathoracic goiters’ locations, we classiﬁed the
intrathoracic goiters to two types. Most intrathoracic goiters were
located anteriorly (pretracheal type) in front of the subclavian,
innominate vessels, and trachea (Fig. 2)15,16. Posterior mediastinal
goiters (retrotracheal type) with a retrotracheal component
constituted 10%e15% of all intrathoracic goiters7; posterior medi-
astinal goiters with retroesophageal extension to the contralateral
hemithorax have been reported but are very rare17. Two such types
are included in our series and imply that goiter development may
be associated with different symptoms that may be related to
a coexisting disease. The most important causes of intrathoracic
goiter are compression of the adjacent organs: the trachea, the
esophagus, and/or the superior vena cava, usually at the level of
the thoracic inlet. This most common complication of pretracheal
type causes compression of trachea with progressive respiratory
distress or vascular circulation. It often affects the esophagus with
dysphagia by the progressive nature of the retrotracheal type.
However, a huge intrathoracic goiter combined with the narrow
passage at the inlet may cause compression of critical organs as
well. Compression of the trachea is commonly reported andmay be
the cause of severe respiratory distress. There was a signiﬁcant
difference between the elderly and younger groups [58 (61.1%)
versus 20 (34.5%), p < 0.001] for tracheal compression. Compres-
sion or deviation of the esophagus is less commondseven (7.4%)
and one (1.7%) in the elderly and younger groups of this
seriesdalthough reported at 70% by Michel and Bradpiece18.
Obstruction of the superior vena cava is uncommon and association
with a benign thyroid mass has been reported infrequently19. Only
three elderly patients and one younger patient with superior vena
cava syndrome were included in this series (3.2% versus 1.7%), all
with colloid goiter. Most authors agree that it is an absolute indi-
cation for operation to prevent their possible complication in the
future, even without any obvious signs of compression20,21.Table 4
Types of intrathoracic goiter.
Types Patients 65 yr Patients <65 yr
(N ¼ 95) (N ¼ 58)
Partial intrathoracic goiter 82 41
Complete intrathoracic goiter 12 17
Ectopic intrathoracic goiter 1 0
Fig. 2. Tumor location of intrathoracic goiter.
Intrathoracic Goiter in the Elderly 11In some conditions, the surgical approach with intrathoracic
goiter is rather different from the cervical goiter because of anatomic
and physiologic variations. Firstly, the primary intrathoracic goiter
(ectopic lesion), the blood supply originates from mediastinal
vessels, may cause severe bleeding that cannot be stopped by a neck
incision. Secondly, the huge intrathoracic goiter was difﬁcult to
remove fromthoracic inletor sufferedahigh-risk injury to thecritical
vital organs (trachea, recurrent laryngeal nerve, esophagus, ormajor
blood vessels). In these situations, the intrathoracic goiters should be
removed through this opening with sternotomy or thoracotomy.
Generally, the surgeon canopen the interclavicular ligament,ﬁnd the
accurate plane, careful dissect mediastinal portion, and gradually
bring out the thoracic part of the tumor all the way through the
thoracic inlet into the cervical incision. Only the anatomic conditions
can be clariﬁed and theprocedure completed. In some cases this step
is impossiblewithout sternotomyor thoracotomy. In our study, there
are 73 (76.8%) elderly patients and 46 (79.3%) younger patients that
only received cervical incision. The other patients needed trans-
thoracic approach to totally remove the goiter. Unfortunately, one
younger patient received cervical incision and died due to a delay in
stopping the intrathoracic bleeding (Table 5).
The histopathologic diagnosis of intrathoracic goiter is similar to
that of cervical goiters. Most of our patients have had multiple
goiters and adenomas. The reported rate of malignancy in the
literature ranges from 3%e17%7,22. Seven (6.9%) younger patients in
our study had malignant thyroid tumor that required total
thyroidectomy. Unlike the effectiveness of ﬁne-needle aspiration in
diagnosing cervical thyroid nodules, needle biopsy of intrathoracic
goiters is quite unsuccessful because of the size and location of
the gland and due to limited cytologic accuracy. Preoperative
diagnosis of malignant intrathoracic goiter might be relatively
difﬁcult to establish. As a result, resection of intrathoracic goiter is
always indicated and, with the exception of patients at prohibitive
risk, should be performed early.Table 5
Histopathological diagnoses of intrathoracic goiter in younger patients.
P’t Sex Age (yrs) Type Size (cm) Histology (carcinoma)
1 F 56 Retro-T 564 Papillary
2 M 62 Retro-T 878 Papillary
3 F 57 Pre-T 88.53 Papillary
4 M 55 Retro-T 854 Follicular
5 M 62 Pre-T 7.55.53 Follicular
6 M 63 Pre-T 553 Hurthle cell
7 F 56 Pre-T 543 Hurthle cell
Re-Tx ¼ re-treatment; F/U ¼ follow up; T4 ¼ thyroid hormone therapy; Pre-T ¼ pre-traAging is associated with increased medical comorbidity, such as
dysfunction of important organs (pulmonary, cardiac, or renal
dysfunction). It explains why previous studies suggested age as
a risk factor for intrathoracic goiter. Our study ﬁrstly described the
outcome of curative surgery between elderly and younger patients
with intrathoracic goiter in the literature. The results indicate that,
although the elderly had greater surgical and in-hospital morbidity,
their overall survivals were similar. The impact of age on survival
and complications from the surgical procedure in patients with
intrathoracic goiter are not well delineated. Data have been sufﬁ-
cient to develop a systematic method for evaluating the risk of
combined modality therapy or surgery in the elderly. Although the
decision to operate depends on a number of factors, our ﬁndings
indicate that an age of 65 years or older should not be considered
a contraindication for intrathoracic goiter. There are many factors,
such as patient symptoms, occult malignance, the use of thyroid
hormonal therapy, and adjuvant therapy, and other clinically
related factors, and others, that inﬂuence the outcome of operative
procedures, including partial or total thyroidectomy and combining
with transthoracic approach. However, recent advances in anes-
thesiologic management and perioperative care have allowed
elderly patients with high surgical risk to undergo operation with
postoperative morbidity andmortality rates comparable to those of
younger individuals. Elderly patients often present with poor
medical and physiologic status and have a higher prevalence of
coexisting cardiopulmonary or cerebrovascular disease. However,
aging is a hazy process with regards to physiologically functional
decrease. This further supports our ﬁndings that age should not be
considered a contraindication for curative surgery in intrathoracic
goiter patients. In this study, surgical morbidity andmortality in the
elderly group was not signiﬁcantly different than that of younger
patients. Additionally, in this study, elderly patients did not have
signiﬁcantly longer postoperative hospital stays than the younger
patients. This is particularly the case when considering the optionsSurgery Recurrent & metastasis Re-Tx F/U
Thoracotomy 3 days
Sternotomy Died due to hypovolemic shock
Sternotomy T4 14 years
Collar incision 4 months
Sternotomy Bone metastasis s/p R/T I131 4 years
Sternotomy 6 months
Collar 7 years
Collar Tracheal invasion T4 6 years
chea; Retro-V ¼ retro-trachea.
W.-C. Huang et al.12for intrathoracic goiter surgery. Elderly patients with intrathoracic
goiter, concerned family members, and medical professionals are
rightly worried about the risks of surgery. Finally, they are required
to have accurate information about potential beneﬁts of intratho-
racic goiter treatment.
5. Conclusion
Elderly patients with intrathoracic goiter who undergo surgery
with curative intent have more airway compressive symptoms and
complications than younger patients. However, elderly individuals
have lessmalignant changes in comparison to their younger patient
counterparts. Therefore, the beneﬁts of surgery for intrathoracic
goiters should not be withheld from patients simply because of
their chronologic age. Both physicians and elderly patients should
consider the differences in risks and the beneﬁts for this surgery
compared with younger patients as an essential part of the
decision-making process. Intrathoracic goiters should be treated
with early surgery rather than running the risk of having aging,
acute airway distress or cancer, unless the patient is unﬁt for
anesthesia or surgery.
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